text: Ongoing research focuses on the the mechanism of leprosy transmission as well as the identification of patients at high risk of infection in order to improve disease prevention and to treat infected individuals earlier.   Identification of alternatives to existing drugs, such as rifampicin is also critical in so far as these agents may be contraindicated either because of toxicity or resistance.
option_0: Leprosy future or investigational therapies
option_1: Leprosy primary prevention
option_2: Tuberculosis future or investigational therapies
option_3: Leprosy tertiary prevention
option_4: HIV coinfection with tuberculosis prevention
option_5: Contact Dermatitis primary prevention
option_6: Tuberculosis secondary prevention
option_7: HIV AIDS medical therapy